MedPath

Syntimmune, Inc.

Syntimmune, Inc. logo
🇺🇸United States
Ownership
Subsidiary
Established
2013-01-01
Employees
1
Market Cap
-
Website
http://syntimmune.com

A Study of SYNT001 in Healthy Volunteers

Early Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Placebo
First Posted Date
2018-08-23
Last Posted Date
2018-08-24
Lead Sponsor
Syntimmune, Inc.
Target Recruit Count
31
Registration Number
NCT03643627
Locations
🇺🇸

Clinical Pharmacology of Miami, Miami, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath